BEGIN:VCALENDAR
PRODID:-//Columba Systems Ltd//NONSGML CPNG/SpringViewer/ICal Output/3.3-
 M3//EN
VERSION:2.0
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
DTSTAMP:20240214T145732Z
DTSTART:20240226T150000Z
DTEND:20240226T160000Z
SUMMARY:Interrogating KRAS ON and OFF signatures to treat KRAS-driven can
 cers: how far can we get?
UID:{http://www.columbasystems.com/customers/uom/gpp/eventid/}g2ut-lslx1s
 pt-2zt1hm
DESCRIPTION:Dr Silve Vincent\, Associate Professor at Center of Applied M
 edical Research in Paloma\, will be joining us to deliver a guest talk o
 n 26th February 2024\, at 15:00-16:00 on 'Interrogating KRAS ON and OFF 
 signatures to treat KRAS-driven cancers: how far can we get?\n\nHosted b
 y Dr. Colin Lindsay at the Oglesby Lecture Theatre\, at the Manchester C
 ancer Research Centre\n\nDr. Silve Vicent\, a distinguished researcher a
 t the University of Navarra\, focuses on molecular targets in KRAS mutan
 t tumors. His work has led to significant advancements in identifying th
 erapeutic strategies for KRAS-driven cancers. \n\nNotably\, he has recei
 ved prestigious awards such as the Leonardo Fellowship in 2018 and the I
 ASLC Young Investigator Award in 2015. \n\nRecently\, Dr. Vicent joined 
 Libera Bio's Scientific Advisory Board\, where his insights are instrume
 ntal in pioneering novel therapeutic approaches for "undruggable" intrac
 ellular targets in cancer therapy.\n\n[https://www.ticketsource.co.uk/un
 iversity-of-manchester-ras/interrogating-kras-on-and-off-signatures-to-t
 reat-kras-driven-cancers-how-far-can-we-get/e-pgvabx Sign up to attend v
 ia TicketSource]\n
STATUS:TENTATIVE
TRANSP:TRANSPARENT
CLASS:PUBLIC
LOCATION:Oglesby (Main) Lecture Theatre\, Manchester Cancer Research Cent
 re (OCRB)\, M20 4GJ
END:VEVENT
END:VCALENDAR